Research and policy priorities for addressing prenatal exposure to opioids in Alaska

References

• Smith VC, Wilson CR. Families affected by parental substance use. Pediatrics. 2016;138(2):e20161575–8.
   PubMed Web of Science ®Google Scholar
• Patrick SW, Davis MM, Lehmann CU, et al. Increasing incidence and geographic distribution of neonatal abstinence syndrome: USA 2009 to 2012. J Perinatol. 2015;35(8):650–655.
   PubMed Web of Science ®Google Scholar
• Davies H, Gilbert R, Johnson K, et al. Neonatal drug withdrawal syndrome: cross-country comparison using hospital administrative data in England, the USA, Western Australia and Ontario, Canada. Arch Dis Child Fetal Neonatal Ed. 2016;101(1):26–30.
   Web of Science ®Google Scholar
• Brown JD, Goodin AJ, Talbert JC. Rural and appalachian disparities in neonatal abstinence syndrome incidence and access to opioid abuse treatment. J Rural Health. July 2017. DOI:10.1111/jrh.12251.
   Web of Science ®Google Scholar
• McQueen K, Murphy-Oikonen J. Neonatal abstinence syndrome. N Engl J Med. 2016;375(25):2468–2479.
   PubMed Web of Science ®Google Scholar
• State of Alaska Epidemiology. Neonatal Abstinence Syndrome among Medicaid-Eligible Births — Alaska, 2004–20. Anchorage, Alaska; 2017 [cited 2017 Aug 3]. http://www.epi.alaska.gov/bulletins/docs/b2017_05.pdf
   Google Scholar
• Ko JY, Patrick SW, Tong VT, et al. Incidence of neonatal abstinence syndrome — 28 states, 1999–2013. MMWR Morb Mortal Wkly Rep. 2016;65(31):799–802.
   PubMed Web of Science ®Google Scholar
• Epstein RA, Bobo WV, Martin PR, et al. Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol. 2013;23(8):498–503.
   Web of Science ®Google Scholar
• Corr TE, Hollenbeak CS. The economic burden of neonatal abstinence syndrome in the USA. Addiction. 2017June;112:1590–1599.
   Web of Science ®Google Scholar
• Hudak ML, Tan RC. Neonatal drug withdrawal. Pediatrics. 2012;129(2):e540–e560.
   PubMed Web of Science ®Google Scholar
• Fischer B, Jones W, Rehm J. Trends and changes in prescription opioid analgesic dispensing in Canada 2005–2012: an update with a focus on recent interventions. BMC Health Serv Res. 2014;14:90.
   Web of Science ®Google Scholar
• Jones HE, Martin PR, Heil SH, et al. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat. 2008;35(3):245–259.
   PubMed Web of Science ®Google Scholar
• Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320–2331.
   PubMed Web of Science ®Google Scholar
• Hall ES, Isemann BT, Wexelblatt SL, et al. A cohort comparison of buprenorphine versus methadone treatment for neonatal abstinence syndrome. J Pediatr. 2016;170:39–44.e1.
   PubMed Web of Science ®Google Scholar
• Broussard CS, Rasmussen SA, Reefhuis J, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011;204(4):314.e1–314.e11.
   Web of Science ®Google Scholar
• Krans EE, Cochran G, Bogen DL. Caring for opioid-dependent pregnant women: prenatal and postpartum care considerations. Clin Obstet Gynecol. 2015;58(2):370–379.
   PubMed Web of Science ®Google Scholar
• Logan BA, Brown MS, Hayes MJ. Neonatal abstinence syndrome: treatment and pediatric outcomes. Clin Obstet Gynecol. 2013;56(1):186–192.
   PubMed Web of Science ®Google Scholar
• Desai RJ, Huybrechts KF, Hernandez-Diaz S, et al. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015;350:h2102.
   PubMed Web of Science ®Google Scholar
• Jansson LM, Velez M, McConnell K, et al. Maternal buprenorphine treatment and fetal neurobehavioral development. Am J Obstet Gynecol. 2017;216(5):529.e1–529.e8.
   Web of Science ®Google Scholar
• Oei J, Lui K. Management of the newborn infant affected by maternal opiates and other drugs of dependency. J Paediatr Child Health. 2007;43(1–2):9–18.
   Web of Science ®Google Scholar
• Holmes AV, Atwood EC, Whalen B, et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics. 2016;137(6):e20152929–e20152929.
   PubMed Web of Science ®Google Scholar
• Kocherlakota P. Neonatal abstinence syndrome. Pediatrics. 2014;134(2):e547–e561.
   PubMed Web of Science ®Google Scholar
• Tolia VN, Patrick SW, Bennett MM, et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. Obstet Gynecol Surv. 2015;70(9):551–552.
   Web of Science ®Google Scholar
• Pritham UA, Paul JA, Hayes MJ. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs. 2012;41(2):180–190.
   PubMed Web of Science ®Google Scholar
• Patrick SW, Schumacher RE, Benneyworth BD, et al. Neonatal abstinence syndrome and associated health care expenditures. JAMA. 2012;307(18):95–98.
   Web of Science ®Google Scholar
• Holtshouser S, Newby-Kew A. Immediate postpartum long acting reversible contraception (LARC) is critical prevention strategy for reducing the number of medicaid enrolled babies affected by Alaska’s opioid epidemic. Anchorage Alaska; 2018.
   Google Scholar
• Alaska State Legislature. Fetal alcohol spectrum disorders and Alaska.
   Google Scholar
• Bada HS, Langer J, Twomey J, et al. Importance of stability of early living arrangements on behavior outcomes of children with and without prenatal drug exposure. J Dev Behav Pediatr. 2008;29(3):173–182.
   PubMed Web of Science ®Google Scholar
• Bada HS, Bann CM, Whitaker TM, et al. Protective factors can mitigate behavior problems after prenatal cocaine and other drug exposures. Pediatrics. 2012;130(6):e1479–e1488.
   Web of Science ®Google Scholar
• Alaska Department of Health and Social Services Office of Children’s Services. Who must report: when am I required to report? 2018 [cited 2018 Oct 28]. http://dhss.alaska.gov/ocs/Pages/childrensjustice/reporting/who_when.aspx
   Google Scholar
• O’Donnell M, Nassar N, Leonard H, et al. Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement. Pediatrics. 2009;123:e614–e621.
   PubMed Web of Science ®Google Scholar
• Taplin S, Mattick RP. The nature and extent of child protection involvement among heroin-using mothers in treatment: high rates of reports, removals at birth and children in care. Drug Alcohol Rev. 2015;34(1):31–37.
   Web of Science ®Google Scholar
• Newby-Kew A, Parrish JW. Understanding child protective services involvement among medicaid enrolled infants with neonatal abstinence syndrome. Under Rev. 2018. [Unpublished].
   Google Scholar
• França UL, Mustafa S, McManus ML. The growing burden of neonatal opiate exposure on children and family services in Massachusetts. Child Maltreat. 2016;21(1):80–84.
   Web of Science ®Google Scholar
• Patrick SW, Schiff DM. A public health response to opioid use in pregnancy. Pediatrics. 2017;139(3):e20164070.
   PubMed Web of Science ®Google Scholar
• Stone R. Pregnant women and substance use: fear, stigma, and barriers to care. Health Justice. 2015;3(1):2.
   Google Scholar
• Schempf AH, Strobino DM, Elman D, et al. Drug use and limited prenatal care: an examination of responsible barriers. Am J Obstet Gynecol. 2009;200(4):412.e1–412.e10.
   Web of Science ®Google Scholar
• Jessup MA, Brindis CD. Issues in reproductive health and empowerment in perinatal women with substance use disorders. J Addict Nurs. 2005;16(3):97–105.
   Web of Science ®Google Scholar
• Terplan M, Kennedy-Hendricks A, Chisolm MS. Prenatal substance use: exploring assumptions of maternal unfitness. Subst Abus Res Treat. 2015;9:1–4.
   Web of Science ®Google Scholar
• Howard H. Reducing stigma: lessons from opioid-dependent women. J Soc Work Pract Addict. 2015;15(4):418–438.
   Web of Science ®Google Scholar
• Ballon BC, Skinner W. “Attitude is a little thing that makes a big difference”: reflection techniques for addiction psychiatry training. Acad Psychiatry. 2008;32(3):218–224.
   PubMed Web of Science ®Google Scholar
• Connery HS. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Harv Rev Psychiatry. 2015;23:63–75.
   Web of Science ®Google Scholar
• Grossman MR, Shapiro ED, Bizzarro MJ, et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics. 2017;139:e20163360.
   Web of Science ®Google Scholar
• Alaska Opioid Policy Task Force. Alaska opioid policy task force: final recommendations. Anchorage, Alaska; 2017 [cited 2018 Sept 29]. http://dhss.alaska.gov/AKOpioidTaskForce/Pages/Meetings.aspx
   Google Scholar
• Alaska Department of Health and Social Services. Perinatal health: printed materials. 2018. [cited 2018 Sept 29]. http://dhss.alaska.gov/dph/wcfh/Pages/perinatal/publications.aspx
   Google Scholar
• Garm A, A. G. The Sheway project. Can Nurse. 1999.
   Google Scholar
• Ordean A, Kahan M, Graves L, et al. Integrated care for pregnant women on methadone maintenance treatment: Canadian primary care cohort study. Can Fam Physician. 2013;59(10):e462–e469.
   Web of Science ®Google Scholar
• Lorraine G, and Poole N, eds. Highs & lows: Canadian perspectives on women and substance use. Centre for Addiction and Mental Health/Centre de toxicomanie et de santé mentale, 2007.
   Google Scholar
• Kelly L, Dooley J, Cromarty H, et al. Narcotic-exposed neonates in a first nations population in northwestern Ontario: incidence and implications. Can Fam Physician. 2011;57(11):e441-e447.
   Web of Science ®Google Scholar
• Jumah NA, Graves L, Kahan M, et al. The management of opioid dependence during pregnancy in rural and remote settings. Cmaj. 2015;187(1):E41–E46.
   Web of Science ®Google Scholar
• State of Alaska. The statewide opioid action plan. Juneau, AK; 2018. http://dhss.alaska.gov/dph/Director/Documents/heroin-opioids/Statewide-Opioid-Action-Plan-2018-2022.pdf
   Google Scholar